Ticker: CBPO, Company: China Biologic Products Holdings, Inc., Type: 6-K, Date: 2018-06-11
Original SEC Filing: Click here

---

Webplus: CBPO/20180611/6-K/2_EX-99.1/000.htm SEC Original: tv496267_ex99-1.htm
FOR RELEASE June 11, 2018 China Biologic Receives CFDA Clinical Trial Approval for Human Fibrin Sealant BEIJING, China – June 11, 2018 – Fibrin Sealant is intended to be used as an adjunct to hemostasis on patients undergoing surgery in case traditional surgical techniques such as sutures, ligatures, and cauteries are ineffective or impractical. China Biologic expects to commence clinical

---

---

Webplus: CBPO/20180611/6-K/1/000.htm SEC Original: tv496267_6k.htm

---

Company Info:

Ticker: CBPO, Company: China Biologic Products Holdings, Inc., Type: 6-K, Date: 2018-06-11CIK: 0001369868, Location: F4, SIC: 2836, SIC Desc: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Business Phone & Address:
18TH FL, JIALONG INTERNATIONALBUILDING, 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT
BEIJING 100125